Theravance Biopharma U.S., Inc.401(k)
THERAVANCE BIOPHARMA U.S., INC. 401(K) PLAN · SOUTH SAN FRANCISCO, CA · plan year 2025
Peer grade: A- · admin costs + employer contributions vs same-size plans · how grading works
Theravance Biopharma U.S., Inc. reported $24,112 in plan administrative expenses for 2025: 0.03% of average plan assets, lower than ~75% of peers. Employer contributions averaged $4,865 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 3 years on file its reported administrative ratio fell from 0.04% to 0.03%. The plan sits in the $50M–$250M size bracket, benchmarked here against 605 comparable plans and shown alongside other professional & technical services employers. By assets it is the 1,052nd-largest of 9,483 plans among California employers on file, and the 1,598th of 11,654 in professional & technical services. In 2025, employees put in $5.40 for every $1.00 the employer contributed; active participation has shrunk from 107 to 85 since 2022.
Theravance Biopharma U.S., Inc.'s 2025 employer contribution ran above the $4,093 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2025 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 463451245 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.